Form4.ai tracks every SEC insider trade in real time. See every OTLC insider filing with a free account — no card.
See every OTLC insider filing — free account, no card.
Free accountOncotelic Therapeutics, Inc. (OTLC) has 1 SEC Form 4 insider filings on record in the last 90 days. That includes 1 insider purchase totalling $24K. Most recent filing: Oct. 30, 2026.
Open-market value, last 90 days
Form 4 filings by type, last 90 days
| Date | Insider | Trade | Value | Price since buy |
|---|---|---|---|---|
| Oct 30, 2026 SEC filing | Trieu Vuong CHAIRMAN AND CEO | Bought | $23,537 | +15.3% 1D |
Create a free account to see the 1 OTLC filing from the last 90 days. No card needed.
Create free accountWant OTLC insider buys the moment they're filed, with Telegram alerts? Try Pro free for 7 days
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.